October 2014, Vol 4, No 6

Arzerra (Ofatumumab) Receives FDA Approval for Patients with Previously Untreated Chronic Lymphocytic Leukemia for Use in Combination with Chlorambucil

By Lisa A. Raedler, PhD, RPh

Drug Updates

FDA-Approved Medications Used for the Treatment of Breast Cancer

Breast Cancer, ICD Codes

Connecting Patients to Resources

By Sheryl A. Riley, RN, OCN, CMCN

Reimbursement

Changes in our economy and healthcare system (ie, the Affordable Care Act, accountable care organizations, evolving reimbursement models) have given birth to a new member of the healthcare team: the financial advocate. Read More ›

CMS Takes Stock of Federal Health Insurance Marketplace Benefits

By Rosemary Frei, MSc

Practice Management

FDA to Regulate Laboratory-Developed Tests

By Rosemary Frei, MSc

Do’s and Don’ts in Physician–Hospital Alignment, Part 2

By Max Reiboldt, CPA

Practice Management

Community–Hospital Relationships: Working Together to Define What Is Right for Patients

By Dawn Holcombe, MBA, FACMPE, ACHE

From the Editor

Disaster Planning for the Oncology Office, Part 2

By Mariana S-B Lamb, MS

Practice Management

October 2014, Vol 4, No 6

Top Trending Articles

CONNECT